Triatomic Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Triatomic Management’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,491	Closed	-$100K	–	27
2024 Q1	$100K	Hold	6,491	–	–	0.19%	24
2023 Q4	$89.6K	Hold	6,491	–	–	0.11%	33
2023 Q3	$74.2K	Hold	6,491	–	–	0.05%	50
2023 Q2	$162K	Buy	6,491 +917	+16%	+$26.9K	0.17%	47
2023 Q1	$202K	Buy	5,574 +394	+8%	+$24.1K	0.14%	48
2022 Q4	$312K	Sell	5,180 -2,574	-33%	-$173K	0.26%	39
2022 Q3	$582K	Sell	7,754 -760	-9%	-$79.4K	0.33%	32
2022 Q2	$976K	Buy	8,514 +1,124	+15%	+$132K	0.9%	22
2022 Q1	$1.4M	Sell	7,390 -8,953	-55%	-$2.07M	1.14%	22
2021 Q4	$5.67M	Buy	+16,343	New	+$6.34M	3.47%	9

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Triatomic Management's OMIC Position: Q2 2024 in Review

Triatomic Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 6,491 shares — an estimated $100K sold.

Triatomic Management first reported a position in OMIC in Q4 2021 and held it in 10 quarters. The position peaked at $5.67M in Q4 2021. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

Triatomic Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Triatomic Management sold 6,491 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $100K.
Triatomic Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Triatomic Management's Singular Genomics Systems, Inc. Common Stock position peaked at $5.67M in Q4 2021.
24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Triatomic Management's 13F filing for Q2 2024, filed 14 Aug 2024.